Intravenous ketamine in refractory depression
Main Authors: | Shivang Gandhi, Bhushan Chaudhari, Suprakash Chaudhury |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
Series: | Medical Journal of Dr. D.Y. Patil Vidyapeeth |
Online Access: | http://www.mjdrdypv.org/article.asp?issn=2589-8302;year=2022;volume=15;issue=6;spage=956;epage=957;aulast=Gandhi |
Similar Items
-
Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression
by: Wei Zheng, et al.
Published: (2021-12-01) -
Intravenous ketamine for refractory bronchospasm precipitated by H1N1 infection
by: Amit eAgrawal, et al.
Published: (2014-04-01) -
Intravenous Ketamine Therapy vs. Electroconvulsive Therapy in Depressive Cases
by: Gholam Reza Kheirabadi, et al.
Published: (2012-01-01) -
Prevalence and correlates of psychiatric comorbidity in patients with epilepsy: A cross-sectional hospital-based study
by: Shivang Gandhi, et al.
Published: (2022-01-01) -
Parenting style and personality correlates of internet addiction: A cross-sectional study
by: Sunil Shivam, et al.
Published: (2021-01-01)